108 related articles for article (PubMed ID: 8940157)
1. Nucleosomal structure of active and inactive c-myc genes.
Pullner A; Mautner J; Albert T; Eick D
J Biol Chem; 1996 Dec; 271(49):31452-7. PubMed ID: 8940157
[TBL] [Abstract][Full Text] [Related]
2. Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II.
Albert T; Mautner J; Funk JO; Hörtnagel K; Pullner A; Eick D
Mol Cell Biol; 1997 Aug; 17(8):4363-71. PubMed ID: 9234694
[TBL] [Abstract][Full Text] [Related]
3. Variable pause positions of RNA polymerase II lie proximal to the c-myc promoter irrespective of transcriptional activity.
Wolf DA; Strobl LJ; Pullner A; Eick D
Nucleic Acids Res; 1995 Sep; 23(17):3373-9. PubMed ID: 7567445
[TBL] [Abstract][Full Text] [Related]
4. Nucleosomes are translationally positioned on the active allele and rotationally positioned on the inactive allele of the HPRT promoter.
Chen C; Yang TP
Mol Cell Biol; 2001 Nov; 21(22):7682-95. PubMed ID: 11604504
[TBL] [Abstract][Full Text] [Related]
5. The chromatin structure of the dual c-myc promoter P1/P2 is regulated by separate elements.
Albert T; Wells J; Funk JO; Pullner A; Raschke EE; Stelzer G; Meisterernst M; Farnham PJ; Eick D
J Biol Chem; 2001 Jun; 276(23):20482-90. PubMed ID: 11279041
[TBL] [Abstract][Full Text] [Related]
6. Differential protein binding to the c-myc promoter during differentiation of hematopoietic cell lines.
Arcinas M; Boxer LM
Oncogene; 1994 Sep; 9(9):2699-706. PubMed ID: 8058334
[TBL] [Abstract][Full Text] [Related]
7. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
8. Changes in in vivo protein-DNA interactions occur at the c-myc P2 promoter during differentiation.
Bryans M; Lang JC; Wilkie NM
Biochem Biophys Res Commun; 1993 Dec; 197(3):1363-9. PubMed ID: 8280153
[TBL] [Abstract][Full Text] [Related]
9. Chromatin structure of transcriptionally active and inactive human c-myc alleles.
Dyson PJ; Littlewood TD; Forster A; Rabbitts TH
EMBO J; 1985 Nov; 4(11):2885-91. PubMed ID: 2998760
[TBL] [Abstract][Full Text] [Related]
10. Reassembly of c-myc and relaxation of c-fos nucleosomes during differentiation of human leukemic (HL-60) cells.
Chou RH; Chen TA; Churchill JR; Thompson SW; Chou KL
Biochem Biophys Res Commun; 1986 Nov; 141(1):213-21. PubMed ID: 3541926
[TBL] [Abstract][Full Text] [Related]
11. Transcription from the P2 promoter of human protooncogene myc is suppressed by retinoic acid through an interaction between the E2F element and its binding proteins.
Ishida S; Shudo K; Takada S; Koike K
Cell Growth Differ; 1994 Mar; 5(3):287-94. PubMed ID: 8018561
[TBL] [Abstract][Full Text] [Related]
12. The role of immunoglobulin kappa elements in c-myc activation.
Hörtnagel K; Mautner J; Strobl LJ; Wolf DA; Christoph B; Geltinger C; Polack A
Oncogene; 1995 Apr; 10(7):1393-401. PubMed ID: 7731690
[TBL] [Abstract][Full Text] [Related]
13. Mapping of DNase I-hypersensitive sites in the upstream DNA of human embryonic epsilon-globin gene in K562 leukemia cells.
Tuan D; London IM
Proc Natl Acad Sci U S A; 1984 May; 81(9):2718-22. PubMed ID: 6232614
[TBL] [Abstract][Full Text] [Related]
14. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters.
Gutsch DE; Marcu KB; Kenney SC
Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):747-60. PubMed ID: 7812182
[TBL] [Abstract][Full Text] [Related]
15. Analysis of human breast cancer nuclear proteins binding to the promoter elements of the c-myc gene.
Miller TL; Jin Y; Sun JM; Coutts AS; Murphy LC; Davie JR
J Cell Biochem; 1996 Mar; 60(4):560-71. PubMed ID: 8707895
[TBL] [Abstract][Full Text] [Related]
16. c-myc intron element-binding proteins are required for 1, 25-dihydroxyvitamin D3 regulation of c-myc during HL-60 cell differentiation and the involvement of HOXB4.
Pan Q; Simpson RU
J Biol Chem; 1999 Mar; 274(13):8437-44. PubMed ID: 10085075
[TBL] [Abstract][Full Text] [Related]
17. The intron enhancer of the immunoglobulin kappa gene activates c-myc but does not induce the Burkitt-specific promoter shift.
Polack A; Strobl L; Feederle R; Schweizer M; Koch E; Eick D; Wiegand H; Bornkamm GW
Oncogene; 1991 Nov; 6(11):2033-40. PubMed ID: 1945409
[TBL] [Abstract][Full Text] [Related]
18. Premature termination of transcription from the P1 promoter of the mouse c-myc gene.
Wright S; Mirels LF; Calayag MC; Bishop JM
Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11383-7. PubMed ID: 1763052
[TBL] [Abstract][Full Text] [Related]
19. Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites.
Goriely S; Demonté D; Nizet S; De Wit D; Willems F; Goldman M; Van Lint C
Blood; 2003 Jun; 101(12):4894-902. PubMed ID: 12576336
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of the MDR1 promoter-enhancing factor 1 (MEF1) in the multidrug resistant HL60/VCR human acute myeloid leukemia cell line.
Ogretmen B; Safa AR
Biochemistry; 2000 Jan; 39(1):194-204. PubMed ID: 10625494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
